Cargando…

Transient akathisia after the SARS-Cov-2 vaccine

We describe a case of transient akathisia after the second dose of the Pfizer COVID-19 vaccine. Movement disorder symptoms such as parkinsonism have been described after other vaccinations and acute COVID-19 infection. This suggests a potential vulnerability of the extrapyramidal system to the immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salinas, Meagen R., Dieppa, Marisara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Correspondence (including Letter to the Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178529/ https://www.ncbi.nlm.nih.gov/pubmed/34113842 http://dx.doi.org/10.1016/j.prdoa.2021.100098

Ejemplares similares

Acute akathisia following initiation of opicapone: A case report
por: Baumgartner, Alexander J., et al.
Publicado: (2022)

SARS-COV-2 induced Parkinsonism: The first case from the sub-Saharan Africa
por: Ayele, Biniyam A., et al.
Publicado: (2021)

Metoclopramide-induced akathisia
por: Chauhan, Gaurav, et al.
Publicado: (2012)

FLUOXETINE INDUCED AKATHISIA AND SUICIDALLY
por: Pandey, S.K.
Publicado: (1999)

T2 hyperintensity in the globus pallidus after Agent Orange exposure
por: Mehanna, Raja, et al.
Publicado: (2019)

RISPERIDONE INDUCED DYSTONIC REACTION AND AKATHISIA
por: Kumar, P.N. Suresh
Publicado: (1999)

RISPERIDONE INDUCED DYSTONIC REACTION AND AKATHISIA
por: Pandey, S.K.
Publicado: (1999)

Gait improvement after levofloxacin administration in a progressive supranuclear palsy patient
por: Kurihara, Masanori, et al.
Publicado: (2020)

Mirtazapine Induced Akathisia: Understanding a Complex Mechanism
por: Raveendranathan, Dhanya, et al.
Publicado: (2015)

Pregnancy in Parkinson's disease with PARK2 mutations()()
por: Sazci, Ali, et al.
Publicado: (2019)

Generalized dystonia without Parkinsonism in an LRRK2 carrier
por: Díaz-Feliz, Lola, et al.
Publicado: (2022)

A patient clinically diagnosed as multiple system atrophy harboring LRRK2 p.G2019S
por: Ando, Shoichiro, et al.
Publicado: (2019)

Healthcare delivery via telehealth during the COVID-19 pandemic: The experience of a Huntington’s disease clinic
por: Klapper, Jennifer, et al.
Publicado: (2021)

Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemic
por: Ahmad, Fadi Abu, et al.
Publicado: (2021)

Electroconvulsive therapy for mania associated with Wilson disease: Improvement in psychiatric and motor symptoms
por: Antonio Bozutti, Luis, et al.
Publicado: (2021)

Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time
por: Schneider, Ruth B., et al.
Publicado: (2021)

Doctor Hope; Calming and Comforting Loneliness in Parkinson’s Disease
por: Virameteekul, Sasivimol, et al.
Publicado: (2022)

Depleting implanted pulse generator (IPG) battery voltage is associated with worsening clinical symptoms in movement disorder patients receiving Deep brain stimulation (DBS)
por: Hamed, Moath, et al.
Publicado: (2019)

Progressive dystonia as a presenting manifestation of GM1 gangliosidosis
por: Mehta, Sahil, et al.
Publicado: (2019)

Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation
por: Delalić, Sentilija, et al.
Publicado: (2020)

Levodopa end-of-dose dystonia successfully treated by neuromuscular taping: A case report
por: Catarci, Teresa, et al.
Publicado: (2020)

Subthalamic stimulation changes motor laterality in Parkinson’s disease
por: Lin, Zhengyu, et al.
Publicado: (2020)

Sexual orientation and gender identity documentation at an academic movement disorders neurology clinic
por: Patel, Roshni Abee, et al.
Publicado: (2022)

Nausea as a non-motor fluctuation in Parkinson’s disease
por: Weisbach, Emily, et al.
Publicado: (2022)

Floating door sign does not differentiate Parkinson’s disease from essential tremor
por: Räty, Valtteri, et al.
Publicado: (2023)

Stable low prevalence of Huntington’s disease in Finland
por: Sipilä, Jussi O.T., et al.
Publicado: (2023)

Tremulous spastic ataxia in a patient with a homozygous truncating SYNE1 variant
por: Spagnolo, Francesca, et al.
Publicado: (2023)

Long-term tonic spinal cord stimulation in advanced Parkinson’s disease: No effect from stimulation under placebo-controlled evaluation
por: Carra, Rafael Bernhart, et al.
Publicado: (2023)

Case clusters of Parkinson’s disease
por: Fuller Torrey, E., et al.
Publicado: (2023)

Immunogenicity of COVID-19 vaccines and levels of SARS-CoV-2 neutralising antibody in the Bruneian population: Protocol for a national longitudinal study
por: Ghani, Hazim, et al.
Publicado: (2022)

A Comment on “Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report”
por: Naguy, Ahmed
Publicado: (2019)

SARS-CoV-2 vaccination complicated by acute, disseminated encephalo-myelitis?
por: Finsterer, Josef
Publicado: (2021)

Application of low-frequency recurrent transcranial magnetic stimulation in the management of aripiprazole-induced akathisias: A case report
por: Kumar, Ajay, et al.
Publicado: (2022)

Transient severe neutropenia in an infant with SARS-CoV-2 infection
por: Irie, Shinji, et al.
Publicado: (2022)

Akathisia after Cyclic Antidepressants Poisoning
por: André-Mathieu, Fleur, et al.
Publicado: (2011)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

Development of Schamberg's disease after SARS‐CoV‐2 vaccination
por: Morimoto, Hiroki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o7b6qq7pln0qadgnibd4ste8dt